Gilder Gagnon Howe & Co’s Guardant Health GH Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.7M	Buy	+104,695	New	+$11.4M	0.16%	108
2023 Q3	–	Sell	-363	Closed	-$13K	–	280
2023 Q2	$13K	Buy	+363	New	+$10.4K	﹤0.01%	306
2022 Q1	–	Sell	-4,167	Closed	-$417K	–	319
2021 Q4	$417K	Sell	4,167 -1,835	-31%	-$190K	﹤0.01%	324
2021 Q3	$750K	Sell	6,002 -147	-2%	-$17.5K	﹤0.01%	332
2021 Q2	$764K	Sell	6,149 -14,968	-71%	-$2.01M	﹤0.01%	342
2021 Q1	$3.22M	Buy	21,117 +12,873	+156%	+$1.95M	0.02%	262
2020 Q4	$1.06M	Sell	8,244 -483	-6%	-$55.6K	0.01%	266
2020 Q3	$976K	Sell	8,727 -261	-3%	-$23.9K	0.01%	260
2020 Q2	$729K	Sell	8,988 -1,265	-12%	-$102K	0.01%	248
2020 Q1	$714K	Buy	10,253 +9,577	+1,417%	+$735K	0.01%	204
2019 Q4	$53K	Hold	676	–	–	﹤0.01%	276
2019 Q3	$43K	Sell	676 -9	-1%	-$793	﹤0.01%	272
2019 Q2	$59K	Sell	685 -1	-0.1%	-$76	﹤0.01%	279
2019 Q1	$53K	Sell	686 -40	-6%	-$2.22K	﹤0.01%	265
2018 Q4	$27K	Buy	+726	New	+$26.7K	﹤0.01%	261

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Gilder Gagnon Howe & Co's GH Position: Q2 2026 in Review

Gilder Gagnon Howe & Co opened a new position in Guardant Health (GH) in Q2 2026: 104,695 shares worth $15.7M. The stake represents 0.16% of the portfolio and ranks #108 among its holdings. This is a return to the name: Gilder Gagnon Howe & Co previously reported a position in GH as recently as Q2 2023.

Gilder Gagnon Howe & Co first reported a position in GH in Q4 2018 and has held it in 15 quarters since. 599 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Gilder Gagnon Howe & Co held 104,695 shares of Guardant Health worth $15.7M as of Q2 2026.
Guardant Health was a new Gilder Gagnon Howe & Co position in Q2 2026.
Guardant Health made up 0.16% of Gilder Gagnon Howe & Co's portfolio in Q2 2026, its #108 holding.
Gilder Gagnon Howe & Co first reported a position in Guardant Health in Q4 2018 and has held it in 15 quarters since.
599 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2026, filed 14 Aug 2026.